
Phorm is on the defensive again. This morning, we got this statement: “There is no substance to today
Subscriber content
?
Subscriber content comes from Gigaom Research, bridging the gap between breaking news and long-tail research. Visit any of our reports to learn more and subscribe.
Advertisement
Advertisement
Advertisement
["wijax_afadf0c7d6a6f416c66b05c4986b8318","wijax_45a8df5c882a910e07b6407003665cce"]
{"source":"https:\/\/gigaom.com\/2009\/04\/22\/419-phorm-says-isp-trialists-not-looking-to-defect\/wijax\/49e8740702c6da9341d50357217fb629","varname":"wijax_105bfb6d77ebeefd42977f5e0cf8683a","title_element":"header","title_class":"widget-title","title_before":"%3Cheader%20class%3D%22widget-title%22%3E","title_after":"%3C%2Fheader%3E"}
{"source":"https:\/\/gigaom.com\/2009\/04\/22\/419-phorm-says-isp-trialists-not-looking-to-defect\/wijax\/49e8740702c6da9341d50357217fb629","varname":"wijax_105bfb6d77ebeefd42977f5e0cf8683a","title_element":"header","title_class":"widget-title","title_before":"%3Cheader%20class%3D%22widget-title%22%3E","title_after":"%3C%2Fheader%3E"}
Comments have been disabled for this post